[Randomized controlled study on the effect of adjuvant immunotherapy with OK-432 on malignant gliomas].
S
S
Shibata
K
K
Mori
T
T
Moriyama
K
K
Tanaka
J
J
Moroki
D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage; D001688:Biological Products / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000532:radiotherapy / Q000628:therapy*; D003131:Combined Modality Therapy; D005260:Female; D005910:Glioma / Q000532:radiotherapy / Q000628:therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D015376:Nimustine; D009607:Nitrosourea Compounds / Q000008:administration & dosage; D010844:Picibanil / Q000627:therapeutic use*; D011897:Random Allocation
D000970:Antineoplastic Agents; D001688:Biological Products; D009607:Nitrosourea Compounds; D015376:Nimustine; D010844:Picibanil